Comparative analysis of DNA flow cytometry and cytology of bladder washings: Review of discordant cases

DNA analysis is becoming an important diagnostic and prognostic adjunct test in urinary cytology. The aim of this study was to compare the results of DNA flow cytometry (FCM) with the cytologic diagnosis of bladder washings (BW). DNA ploidy was evaluated in 251 BW. In 65 cases, follow‐up surgical biopsies were available. Cytology results were classified as positive and negative, and FCM results were categorized as diploid and aneuploid. Both tests were evaluated independently. Cases were defined as discordant if the cytology was negative and FCM was aneuploid, or if the cytology was positive and FCM was diploid. All discordant cases were reviewed, and positive predictive values (PPV) for FCM and cytology were calculated for cases with follow‐up biopsy results. Cytologic evaluation classified 181 cases as negative, with 175 of them diploid and 6 aneuploid; and 70 as positive, with 53 of them diploid and 17 aneuploid. Overall, there were 59 discordant cases (23.5%, with a confidence limit of 18.2–28.8%). Of 6 aneuploid/cytology‐negative cases, biopsies were available in 4 cases and showed one grade 1, two grade 2, and one grade 3 urothelial carcinoma (UC). Reanalysis of these 6 cytology specimens showed 1 case that should have been interpreted as positive (false negative), 4 true negatives, and 1 polyoma virus infection. Out of 53 diploid/cytology‐positive cases, biopsies were available in 45 cases and showed nine grade 1, 14 grade 2, three grade 3 UCs, 11 UCs in situ, and eight negative biopsies. The PPV for cytology was 85%, and the PPV for FCM was 95%. We concluded that FCM, which requires a large number of cells, often cannot detect small aneuploid populations, which are present particularly in cases of UC in situ. Diagn. Cytopathol. 2000;22:65–69. © 2000 Wiley‐Liss, Inc.

[1]  F. Meyer,et al.  Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors. , 1997, The Journal of urology.

[2]  C. Cornelisse,et al.  Assessment of Genetic Changes in Human Cancers Using Flow and Image Cytometry , 1997 .

[3]  B. C. Wright,et al.  Comparative analysis of DNA content in polyomavirus-infected urothelial cells, urothelial dysplasia and high grade transitional cell carcinoma. , 1997, Analytical and quantitative cytology and histology.

[4]  D. Johnston,et al.  DNA image analysis of urinary cytology: prediction of recurrent transitional cell carcinoma. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[5]  C. Gilks,et al.  Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice: a prospective study. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[6]  A. Vecchione,et al.  Biologic characteristics of T1 papillary bladder cancer. Flow cytometric study of paraffin-embedded material. , 1995, Analytical and quantitative cytology and histology.

[7]  J. Pow-Sang,et al.  Role of DNA image cytometry in the follow-up of patients with urinary tract transitional cell carcinoma. , 1993, Analytical and quantitative cytology and histology.

[8]  L. Wheeless,et al.  Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference. , 1993, Cytometry.

[9]  M. Benson,et al.  The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder. , 1992, The Journal of urology.

[10]  R. Colvin,et al.  Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy. , 1992, The Journal of urology.

[11]  M. Melamed,et al.  Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer. , 1990, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[12]  L. Koss,et al.  Predictive value of DNA measurements in bladder washings. Comparison of flow cytometry, image cytophotometry, and cytology in patients with a past history of urothelial tumors , 1989, Cancer.

[13]  P. Schellhammer,et al.  Flow cytometric study comparing paired bladder washing and voided urine for bladder cancer detection. , 1989, Urology.

[14]  B. Barlogie,et al.  Acridine‐orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder: The influence of prior local therapy , 1987, Cancer.

[15]  D. Cowan,et al.  Correlation of histopathological, cytological and flow cytometric findings in neoplastic and nonneoplastic lesions of the bladder. , 1987, The Journal of urology.

[16]  M. Melamed,et al.  The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma , 1987, Cancer.

[17]  M. Soloway,et al.  Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. , 1986, The Journal of urology.

[18]  C. Olsson,et al.  Flow cytometry: role in monitoring transitional cell carcinoma of bladder. , 1986, Urology.

[19]  P. Nichols,et al.  A simple and practical technic for detecting cancer cells in urine and urinary bladder washings by flow cytometry. , 1985, American journal of clinical pathology.

[20]  M. Melamed,et al.  An evaluation of automated flow cytometry (FCM) in detection of carcinoma in situ of the urinary bladder , 1982, Cancer.

[21]  M. Melamed,et al.  Detection and follow‐up of carcinoma of the urinary bladder by flow cytometry , 1982, Cancer.